Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls

Clinical Microbiology and Infection

Volumn 17, Issue 12, 2011, Pages 1875-1881

  Gammelsrud, K W ^a,b   Sandven, P ^c   Hoiby E A ^c   Sandvik, L ^a   Brandtzaeg, P ^a,b   Gaustad, P ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cancer; Candida; Children; Colonization; Cystic fibrosis

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; METRONIDAZOLE; PENICILLIN V; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CYSTIC FIBROSIS; FECES ANALYSIS; FEMALE; FUNGAL COLONIZATION; HUMAN; HUMAN TISSUE; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; NORWAY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPECIES DISTRIBUTION; THROAT CULTURE;

CANDIDA; CANDIDA ALBICANS;

EID: 81255158854     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03528.x     Document Type: Article

References (30)

1. Walsh TJ, Roilides E, Groll AH, Gonzalez C, Pizzo PA. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 2006; 5th ed. 1296-1329.
2. Leon C, Ruiz-Santana S, Saavedra P et al. Usefulness of the 'Candida score' for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009; 37: 1624-1633.
3. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-758.
4. Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2008; 9: 91-95.
5. Brillowska-Dabrowska A, Bergmann O, Jensen IM, Jarlov JO, Arendrup MC. Typing of Candida isolates from patients with invasive infection and concomitant colonization. Scand J Infect Dis 2010; 42: 109-113.
6. Miranda LN, van der Heijden IM, Costa SF et al. Candida colonisation as a source for candidaemia. J Hosp Infect 2009; 72: 9-16.
7. Kirkby S, Novak K, McCoy K. Update on antibiotics for infection control in cystic fibrosis. Expert Rev Anti Infect Ther 2009; 7: 967-980.
8. Chotirmall SH, Greene CM, McElvaney NG. Candida species in cystic fibrosis: a road less travelled. Med Mycol 2010; 48: S114-S124.
9. Al Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar. J Clin Microbiol 2003; 41: 4787-4789.
10. Turin L, Riva F, Galbiati G, Cainelli T. Fast, simple and highly sensitive double-rounded polymerase chain reaction assay to detect medically relevant fungi in dermatological specimens. Eur J Clin Invest 2000; 30: 511-518.
11. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection and biochemical methods for species identification. J Clin Microbiol 2002; 40: 2483-2489.
12. Marklein G, Josten M, Klanke U et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009; 47: 2912-2917.
13. Odds FC. Ecology of Candida and epidemiology of candidosis. In: Odds FC, ed. Candida and candidosis: a review and bibliography. London: Bailliere Tindall, 1988; 68-92.
14. Agirbasli H, Ozcan SA, Gedikoglu G. Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients. Mycopathologia 2005; 159: 515-520.
15. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 2001; 33: 1959-1967.
16. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999-1004.
17. Rafii F, Sutherland JB, Cerniglia CE. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther Clin Risk Manag 2008; 4: 1343-1358.
18. Samonis G, Anaissie EJ, Bodey GP. Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother 1990; 34: 2420-2422.
19. Samonis G, Anastassiadou H, Dassiou M, Tselentis Y, Bodey GP. Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans. Antimicrob Agents Chemother 1994; 38: 602-603.
20. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1: 101-114.
21. Sakata H, Fujita K, Yoshioka H. The effect of antimicrobial agents on fecal flora of children. Antimicrob Agents Chemother 1986; 29: 225-229.
22. Gotzsche PC, Johansen HK. Nystatin prophylaxis and treatment in severely immunodepressed patients. Cochrane Database Syst Rev 2002: CD002033.
23. Odds FC, Kibbler CC, Walker E, Bhamra A, Prentice HG, Noone P. Carriage of Candida species and C. albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease. J Clin Pathol 1989; 42: 1259-1266.
24. Maraki S, Hajiioannou I, Anatoliotakis N et al. Ceftriaxone and dexamethasone affecting yeast gut flora in experimental mice. J Chemother 1999; 11: 363-366.
25. Samonis G, Karyotakis NC, Anaissie EJ et al. Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans. Antimicrob Agents Chemother 1996; 40: 2221-2223.
26. Nordoy I, Gaustad P, Sandven P. Abstract P105: Candidemia in Norway: a 5 year follow-up of a nationwide study. Mycoses 2009; 52 (suppl 1): 66-67.
27. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P. Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 2006; 44: 1977-1981.
28. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A; CLSI Subcommittee for Antifungal Susceptibility Testing. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 2010; 13: 180-195.
29. Pfaller MA, Diekema DJ, Andes D et al. Clinical breakpoints for the echinocandins and the Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 2001; 14: 164-176.
30. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986; 15: 386-388.